The ViKCoVaC Study

The ViKCoVaC Study

CONDITION

Cardiovascular

GENDER

Both males and females

AGE GROUP

50 years to 80 years

TRIAL STATUS

Recruiting

Are you aged between 50 and 80?
Do you have Diabetes?
You could play a role in the
prevention of heart disease by
participating in the ViKCoVaC study.
Led by Winthrop Professor and
Cardiologist Carl Schultz, Royal Perth
Hospital’s cardiology team are seeking
Diabetes patients to be involved in a
study that looks at calcium build up or
“hardening of arteries” in the heart – a
key indicator of heart disease.
The VikCoVac research study will investigate the effects of
Vitamin K and Colchicine on vascular calcification activity.
You will be asked to:
– participate in a three month trial
– attend monthly clinic appointments at Royal Perth Hospital
– take daily medication for the duration of the trial.
What benefits do I receive?
– No impact on your current medication.
– Flexibility to fit clinic appointments into your
personal schedule.
– No associated cost for calcium scans or other study activities.
– An opportunity to help investigate the prevention of
heart disease.
If this sounds like something you would like to
participate in please speak to your GP for a referral.
Alternatively you can contact the study coordinator or visit the
Royal Perth Hospital website (www.rph.wa.gov.au) for
more information.
Royal Perth Hospital Study Coordinator
Dr Jamie Bellinge
(08) 9224 3181 or 0474 738 890
Jamie.Bellinge@health.wa.gov.au

CONTACT DETAILS

Phone Number: 9224 3181 or 0474738890
Email: Jamie.Bellinge@health.wa.gov.au
Location: Royal Perth Hospital Eastbound, 197 Wellington St, Perth, 6000

CONTACT SITE

Approved By: Royal Perth Hospital Human Research Ethics Committee              

Clinical Trial Registry Link: Click Here